GIC Sub-Industry »Pharmaceuticals« (99)
| Symbol | Industry | Market Cap | VRT | Buy Signal | Risk | RS (IBD) | Div. Yield |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
975B | 78.4 | 0.25 | 92.4 | 78 | 0.74% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Immunology, Oncology |
526B | 76.3 | 0.77 | - | 86 | 3.02% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
292B | 66.5 | -0.15 | 68.8 | 71 | 2.08% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
288B | 66.6 | -0.15 | 69 | 78 | 2.08% |
| NVS Novartis |
Pharmaceuticals
Oncology, Immunology |
278B | 90.3 | 0.29 | 93.4 | 82 | 3.68% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Glucagon, Obesity |
277B | 60.2 | -1.29 | 82.3 | 21 | 2.67% |
| MRK Merck |
Pharmaceuticals
Oncology Vaccines, Antibiotics |
273B | 75.3 | 0.35 | 100 | 78 | 3.70% |
| PFE Pfizer |
Pharmaceuticals
Vaccines, Antibiotics, Oncology |
148B | 56.5 | -0.44 | 100 | 54 | 8.75% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Insulin, Rare Disease |
115B | 32.4 | -2.17 | - | 14 | 4.43% |
| SAN Sanofi |
Pharmaceuticals
Vaccines, Immunology, Neurology |
115B | 53.2 | -2.44 | 100 | 12 | 4.30% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Immunology, Hematology |
111B | 60.9 | -0.19 | 82.8 | 70 | 6.08% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Hiv, Oncology |
100B | 72.5 | -0.24 | 75.5 | 77 | 4.18% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Oncology, Respiratory |
99.3B | 74.1 | 0.82 | 63.5 | 82 | 4.20% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Pharmaceuticals |
66.5B | 49.5 | 0.33 | 99.3 | 39 | 1.79% |
| ZTS Zoetis |
Pharmaceuticals
Medicines, Vaccines, Diagnostics |
55.4B | 56.9 | -1.61 | 100 | 9 | 1.76% |
| TAK Takeda |
Pharmaceuticals
Oncology, Gastroenterology |
54.2B | 54.3 | -0.04 | 72.6 | 72 | 4.48% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
52.4B | 52.9 | 0.20 | 68.1 | 94 | 0.48% |
| TEVA Teva Pharma |
Pharmaceuticals
Generics, Respiratory, CNS |
36.3B | 49.1 | 2.10 | 29.2 | 94 | - |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Biopharma, Investments |
23.6B | 59.7 | 0.21 | - | 69 | 2.48% |
| VTRS Viatris |
Pharmaceuticals
Prescription, Generic, Biosimilar |
15.3B | 49.8 | -0.29 | 49.9 | 85 | 4.98% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Rare Disease |
13.7B | 89.1 | -0.55 | 90.2 | 75 | 1.34% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
12.1B | 44.6 | 0.49 | 59.6 | 93 | - |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.5B | 49.3 | -1.02 | 100 | 17 | 0.62% |
| JAZZ Jazz |
Pharmaceuticals
Sleep Disorder, Epilepsy, Oncology |
10.3B | 60.2 | -0.60 | 66 | 83 | - |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Anti-Sleepiness |
9.37B | 51.1 | 0.63 | 0 | 92 | - |
| CORT Corcept |
Pharmaceuticals
Korlym, Relacorilant |
4.63B | 41.3 | -0.95 | 100 | 5 | - |
| TERN Terns |
Pharmaceuticals
Kinase Inhibitor, Thyroid Agonist |
3.73B | 35.0 | -0.15 | - | 99 | - |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.70B | 81.6 | -0.04 | 96.6 | 46 | 0.45% |
| LQDA Liquidia |
Pharmaceuticals
Treprostinil, Inhaled, Injectable |
3.53B | 48.4 | 0.88 | 0 | 97 | - |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic Powders, Diaper Rash |
3.23B | 44.8 | -1.66 | 97 | 13 | - |
| TARS Tarsus |
Pharmaceuticals
XDEMVY, TP-04, TP-05, Lotilaner |
2.90B | 44.2 | -1.64 | 14.9 | 72 | - |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.77B | 57.4 | -0.10 | 94.5 | 75 | - |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
2.54B | 40.5 | -1.03 | 82.6 | 20 | 2.58% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, Obesity, Duchenne |
2.50B | 33.9 | -1.22 | 0 | 91 | - |
| MAZE Maze Therapeutics |
Pharmaceuticals
MZE829, MZE782, MZE001, Renal |
2.22B | 47.3 | 1.32 | - | 98 | - |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.19B | 36.6 | -1.69 | 47.4 | 13 | - |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dextenza, Axpaxli, Paxtrava |
2.19B | 32.3 | -1.40 | 0 | 35 | - |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, Orexin-Agonist |
2.17B | 73.9 | -0.23 | 100 | 65 | - |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.17B | 60.5 | -0.53 | 93.2 | 26 | 2.59% |
| AVDL Avadel |
Pharmaceuticals
Sodium Oxybate, Narcolepsy |
2.11B | 59.5 | -0.47 | 0 | 95 | - |
| PRGO Perrigo |
Pharmaceuticals
OTC Medicines, Infant Nutrition |
2.03B | 23.8 | -1.20 | 75.4 | 3 | 5.51% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
1.86B | 58.2 | -0.90 | 83.8 | 45 | - |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, AMX0035, AMX0114 |
1.73B | 47.0 | -0.36 | 0 | 97 | - |
| INVA Innoviva |
Pharmaceuticals
COPD/Asthma Inhalers, Antibiotics |
1.66B | 65.0 | -0.88 | 100 | 45 | - |
| HROW Harrow Health |
Pharmaceuticals
Eye, Gel, Drops, Steroid |
1.65B | 43.7 | -0.47 | 58.1 | 81 | - |
| PAHC Phibro Animal |
Pharmaceuticals
Antibacterials, Anticoccidials |
1.60B | 53.4 | -0.46 | 98 | 88 | 1.60% |
| ELVN Enliven |
Pharmaceuticals
Kinase Inhibitor, HER2 Inhibitor |
1.53B | 25.7 | -0.64 | - | 76 | - |
| EVT Evotec SE |
Pharmaceuticals
Drug Discovery, Development |
1.52B | 11.6 | -0.12 | 36.2 | 12 | - |
| COLL Collegium |
Pharmaceuticals
Stimulant, Buprenorphine Film |
1.44B | 68.6 | -0.39 | 70.2 | 87 | - |
| RAPP Rapport |
Pharmaceuticals
Epilepsy, Neuropathic Pain |
1.28B | 35.9 | -0.11 | - | 90 | - |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Chronic Cough, IPF, Refractory |
1.28B | 36.4 | -0.55 | - | 90 | - |
| EYPT Eyepoint |
Pharmaceuticals
Durasert, Duravyu, EYP-2301 |
1.26B | 46.0 | -0.24 | 0 | 92 | - |
| XERS Xeris |
Pharmaceuticals
Glucagon, Periodic Paralysis |
1.25B | 54.6 | -1.35 | 0 | 83 | - |
| AMPH Amphastar P |
Pharmaceuticals
Injectable, Inhalation |
1.21B | 50.4 | -0.83 | 100 | 28 | - |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
1.15B | 57.6 | -0.37 | 0 | 93 | - |
| PHAT Phathom |
Pharmaceuticals
Antibiotic, Regimen, Reflux |
1.11B | 64.1 | -0.57 | 0 | 94 | - |
| CRON Cronos |
Pharmaceuticals
Dried Flowers, Pre-Rolls, Oils |
1.06B | 50.4 | 0.14 | 100 | 79 | - |
| TLRY Tilray |
Pharmaceuticals
Cannabis, Beverage, Hemp |
1.05B | 14.1 | -1.36 | 0 | 16 | - |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Norepinephrine |
1.05B | 63.7 | 0.27 | 0 | 93 | - |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735, VTX3242 |
1.00B | 45.8 | 0.83 | 0 | 99 | - |
| ARVN Arvinas |
Pharmaceuticals
Protac, Degrader, Breast |
946M | 34.4 | 0.10 | 0 | 82 | - |
| PCRX Pacira BioSciences |
Pharmaceuticals
Bupivacaine Liposome |
889M | 39.4 | -1.29 | 79.3 | 13 | - |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
846M | 34.0 | -0.39 | 0 | 93 | - |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Autoimmune, Inflammation, Cancer |
774M | 47.6 | -1.47 | 0 | 93 | - |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
709M | 46.5 | -0.67 | 0 | 94 | - |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
678M | 45.0 | 0.51 | - | 99 | - |
| NBY NovaBay |
Pharmaceuticals
Wound Cleanser, Hypochlorous Acid |
594M | 50.9 | -0.69 | 0 | 99 | 62.50% |
| CRMD CorMedix |
Pharmaceuticals
Antimicrobial, Catheter, Solution |
542M | 55.3 | -0.90 | 0 | 5 | - |
| ANRO Alto Neuroscience |
Pharmaceuticals
Antidepressant, Cognitive |
510M | 40.0 | -1.10 | - | 99 | - |
| ACRS Aclaris |
Pharmaceuticals
JAK, TSLP, ITK, MAPK, Bi-Specific |
488M | 38.4 | -0.81 | 0 | 94 | - |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
481M | 11.4 | -0.87 | 0 | 11 | - |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox Treatment |
476M | 68.6 | -1.03 | 100 | 20 | 10.42% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
475M | 39.3 | 0.42 | - | 95 | - |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Alcohol, Retail, Flower |
422M | 37.4 | -0.81 | 93.7 | 14 | - |
| ETON Eton |
Pharmaceuticals
Adrenal, Wilson, PKU, Tyrosinemia |
402M | 36.8 | -1.53 | 0 | 12 | - |
| AQST Aquestive |
Pharmaceuticals
Buccal Film, Sublingual Film, Oral |
395M | 36.1 | -1.30 | 0 | 8 | - |
| NMRA Neumora |
Pharmaceuticals
Depression, Agitation, Alzheimer |
350M | 20.7 | -1.40 | - | 76 | - |
| RLMD Relmada |
Pharmaceuticals
Gemcitabine, Docetaxel |
331M | 36.2 | 0.19 | - | 99 | - |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Small-Molecule |
327M | 14.9 | -0.87 | - | 48 | - |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
322M | 39.5 | -0.62 | - | 72 | - |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
319M | 23.4 | -1.78 | 0 | 2 | - |
| ACB Aurora Cannabis |
Pharmaceuticals
Cannabis, Oils, Capsules, Edibles |
251M | 40.4 | -1.27 | 0 | 17 | - |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading, Payment, Tokenization |
239M | 16.2 | -1.44 | 0 | 2 | - |
| MDWD Mediwound |
Pharmaceuticals
Burn Debridement, Chronic Wound |
231M | 13.3 | -0.11 | 0 | 20 | - |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis, Flower, Pre-Rolls |
222M | 20.1 | -0.67 | 0 | 53 | - |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Diseases |
177M | 37.3 | -0.30 | - | 96 | - |
| MIST Milestone |
Pharmaceuticals
Calcium Channel Blocker |
169M | 18.7 | -0.85 | - | 67 | - |
| CNTX Context |
Pharmaceuticals
Anti-Claudin6 Bispecific, T-Cell |
166M | 34.8 | 1.53 | - | 98 | - |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Cancer Vaccines, Peptide Therapy |
143M | 15.4 | -1.13 | - | 27 | - |
| SAVA Cassava Sciences |
Pharmaceuticals
Drug, Diagnostic, Alzheimer |
142M | 8.4 | -1.03 | 0 | 10 | - |
| VRCA Verrica |
Pharmaceuticals
Cantharidin, VP-102, VP-315 |
119M | 44.7 | -0.90 | 0 | 90 | - |
| SLGL Sol Gel |
Pharmaceuticals
Acne Cream, Rosacea Cream, Gorlin |
99.1M | 53.8 | 0.72 | 0 | 99 | - |
| SCLX Scilex Holding |
Pharmaceuticals
Patch, Migraine, Gout, Sciatica |
66.4M | 49.0 | -1.80 | 0 | 8 | - |
| LPCN Lipocine |
Pharmaceuticals
Testosterone, Oral, CNS, Prodrug |
60.6M | 44.9 | -0.23 | 0 | 99 | - |
| CPIX Cumberland |
Pharmaceuticals
Injection, Acetaminophen, Pain |
56.1M | 61.8 | -0.19 | 49.1 | 68 | - |
| EVOK Evoke Pharma |
Pharmaceuticals
Nasal Spray, Diabetic Gastroparesis |
19.0M | 52.5 | 0.79 | - | 99 | - |
| KALA Kala |
Pharmaceuticals
KPI-012, KPI-014, Eye Therapy |
16.2M | 17.5 | -1.28 | - | 1 | - |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual Tablets, Aspirin |
7.54M | 12.3 | -1.85 | - | 1 | - |
| YCBD cbdMD |
Pharmaceuticals
CBD Tinctures, Gummies, Topicals |
6.58M | 19.6 | -1.38 | 0 | 3 | - |